3,4-methylenedioxyamphetamine has been researched along with Carcinoma, Embryonal in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Carcinoma, Embryonal: A highly malignant, primitive form of carcinoma, probably of germinal cell or teratomatous derivation, usually arising in a gonad and rarely in other sites. It is rare in the female ovary, but in the male it accounts for 20% of all testicular tumors. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, p1595)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montine, TJ | 1 |
| Amarnath, V | 1 |
| Martin, ME | 1 |
| Strittmatter, WJ | 1 |
| Graham, DG | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Carcinoma, Embryonal
| Article | Year |
|---|---|
E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures.
Topics: 3,4-Methylenedioxyamphetamine; Aldehydes; Carcinoma, Embryonal; Cytoskeletal Proteins; Lipid Peroxid | 1996 |